ITA0650
ITA0650
- Catalog: ITA0650
- Gene/Protein: BCL9L
- Product Description: Immunotag™ Phospho-BCL9L (Ser915) Antibody
385.0000
Price in reward points: 385
Your shopping cart is empty!
Antibody Specification | |
Datasheet | |
Target Protein | Phospho-BCL9L (Ser915) |
Clonality | Polyclonal |
Storage/Stability | -20°C/1 year |
Application | WB,IHC |
Recommended Dilution | WB 1:500-1:2000, IHC 1:50-1:200 |
Concentration | 1 mg/ml |
Reactive Species | Human,Mouse,Rat |
Host Species | Rabbit |
Immunogen | A synthesized peptide derived from human BCL9L around the phosphorylation site of Ser915. |
Specificity | Phospho-BCL9L (Ser915) Antibody detects endogenous levels of BCL9L. |
Purification | The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho- and non-phospho-peptide affinity columns. |
Form | Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.Store at -20 °C.Stable for 12 months from date of receipt |
Gene Name | BCL9L |
Accession No. | Q86UU0 |
Alternate Names | B-cell CLL; B-cell CLL/lymphoma 9-like protein; B-cell lymphoma 9-like protein; B9L; BCL9-2; BCL9-like protein; BCL9-related beta-catenin-binding protein; Bcl9l; BCL9L_HUMAN; DLNB11; Nuclear co factor of beta catenin signalling; Protein BCL9-2; |
Description | Transcriptional regulator that acts as an activator. Promotes beta-catenin transcriptional activity. Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1 (By similarity). |
Cell Pathway/ Category | Primary Polyclonal Antibody |
Protein MW | 200kDa |
Usage | For Research Use Only! Not for diagnostic or therapeutic procedures. |